Siegfried (SIX: SFZN), a global Contract Development and Manufacturing Organization (CDMO), has announced the appointment of Eduardo Montanha as Chief Operating Officer and member of the Executive Committee, effective September 1, 2026. The move follows the company's decision to combine the Chief Operating Officer roles for Drug Substances and Drug Products into a single position, aligning with its strategy to provide integrated end-to-end solutions across the pharmaceutical value chain.
Montanha brings more than 20 years of international leadership experience in pharmaceutical and biopharmaceutical manufacturing. He most recently served as Executive Vice President, Head of Global Technical Operations & Quality at Fresenius Kabi, where he led an integrated global network of approximately 30 manufacturing sites across multiple regions. Earlier in his career, he held senior leadership positions at Takeda, Sandoz, Hexal, and Hoechst/Aventis, covering technical operations, quality, supply, and large-scale manufacturing networks.
“I am very pleased to welcome Eduardo to Siegfried. He brings outstanding global operations and quality leadership experience and will play an important role in further enhancing supply performance, operational efficiency and reliability for our customers,” said Marcel Imwinkelried, Chief Executive Officer of Siegfried.
With his strong track record in integrated operations, Montanha will focus on strengthening supply performance, operational efficiency, and reliability across Siegfried's global network. The company operates 16 sites in Switzerland, Germany, Spain, France, Malta, the USA, Australia, and China, and in 2025 achieved sales of CHF 1,327.8 million with more than 3,800 employees.
Montanha holds a bachelor's degree in chemical engineering, a postgraduate qualification in Industrial Automation, and an MBA in Project Management. He has lived and worked across Europe and Latin America, bringing extensive international leadership experience to his new role.
The appointment underscores Siegfried's commitment to streamlining operations and enhancing its ability to offer comprehensive CDMO services, from drug substances to drug products. For more information about Siegfried's leadership and strategy, visit www.siegfried.ch. The original press release is available at www.newmediawire.com.
